Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures

Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine carboxamide family that is currently approved as adjunctive therapy and monotherapy for partial-onset (focal) seizures. The drug enhances slow inactivation of voltage-gated sodium channels and subsequently reduces th...

Descripción completa

Detalles Bibliográficos
Autores principales: Galiana, Graciana L., Gauthier, Angela C., Mattson, Richard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629137/
https://www.ncbi.nlm.nih.gov/pubmed/28741150
http://dx.doi.org/10.1007/s40268-017-0197-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629137/
https://www.ncbi.nlm.nih.gov/pubmed/28741150
http://dx.doi.org/10.1007/s40268-017-0197-5

Ejemplares similares